| Dr Mark Pozsgay, DO | |
|
95 Arch St, Suite 255, Akron, OH 44304-1437 | |
| (330) 761-9930 | |
| (330) 761-9936 |
| Full Name | Dr Mark Pozsgay |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 20 Years |
| Location | 95 Arch St, Akron, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194972109 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 34.008832 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summa Health System | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summa Physicians Inc | 2961303532 | 640 |
News Archive
The COVID-19 pandemic has caused rapid adoption, integration and development of artificial intelligence and machine learning into the healthcare industry.
The U.S. Departments of Agriculture and Interior has announced that routine surveillance has indicated the presence of H5 and N1 avian influenza subtypes in samples from two wild mute swans in Michigan.
Researchers at the University of Colorado School of Medicine and The Children's Hospital have taken a big step toward understanding what causes one of the most serious liver diseases in infants.
ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) clearance of CarriGen® Porous Bone Substitute Material. CarriGen is available for immediate sale through ETEX's independent sales force. CarriGen builds upon the clinically proven benefit of ETEX nanocrystalline calcium phosphate technology by adding the advantage of increased porosity and pore size. CarriGen is the first highly porous bone graft substitute that sets hard upon implantation for a complete defect fill.
› Verified 9 days ago
| Entity Name | Summa Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235167719 PECOS PAC ID: 2961303532 Enrollment ID: O20040116000295 |
News Archive
The COVID-19 pandemic has caused rapid adoption, integration and development of artificial intelligence and machine learning into the healthcare industry.
The U.S. Departments of Agriculture and Interior has announced that routine surveillance has indicated the presence of H5 and N1 avian influenza subtypes in samples from two wild mute swans in Michigan.
Researchers at the University of Colorado School of Medicine and The Children's Hospital have taken a big step toward understanding what causes one of the most serious liver diseases in infants.
ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) clearance of CarriGen® Porous Bone Substitute Material. CarriGen is available for immediate sale through ETEX's independent sales force. CarriGen builds upon the clinically proven benefit of ETEX nanocrystalline calcium phosphate technology by adding the advantage of increased porosity and pore size. CarriGen is the first highly porous bone graft substitute that sets hard upon implantation for a complete defect fill.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Pozsgay, DO 95 Arch St, Suite 255, Akron, OH 44304-1437 Ph: (330) 761-9930 | Dr Mark Pozsgay, DO 95 Arch St, Suite 255, Akron, OH 44304-1437 Ph: (330) 761-9930 |
News Archive
The COVID-19 pandemic has caused rapid adoption, integration and development of artificial intelligence and machine learning into the healthcare industry.
The U.S. Departments of Agriculture and Interior has announced that routine surveillance has indicated the presence of H5 and N1 avian influenza subtypes in samples from two wild mute swans in Michigan.
Researchers at the University of Colorado School of Medicine and The Children's Hospital have taken a big step toward understanding what causes one of the most serious liver diseases in infants.
ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) clearance of CarriGen® Porous Bone Substitute Material. CarriGen is available for immediate sale through ETEX's independent sales force. CarriGen builds upon the clinically proven benefit of ETEX nanocrystalline calcium phosphate technology by adding the advantage of increased porosity and pore size. CarriGen is the first highly porous bone graft substitute that sets hard upon implantation for a complete defect fill.
› Verified 9 days ago
Derek Cody, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3925 Embassy Parkway, Suite 300, Akron, OH 44333 Phone: 330-668-4065 Fax: 330-668-4082 | |
Dr. Mark L. Wulkan, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-1000 | |
Sophia Horattas, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 | |
Avraham David Schlager, Surgery Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-6060 Fax: 330-543-6069 | |
Dennis Wright, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, #3500, Akron, OH 44307 Phone: 330-344-1400 Fax: 330-344-0112 | |
Dr. Andrei Cocieru, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 75 Arch St, Suite 103, Akron, OH 44304 Phone: 330-253-5335 Fax: 330-253-6233 | |
Katharine Tavani, NP Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-1000 |